Rosso F, Maffione G
aleas s.p.a., Milano.
Boll Chim Farm. 1991 Oct;130(9):355-71.
Cyclodextrins are known to form inclusion complexes in acqueous solutions with various types of organic substance, also a lot of hydrophobic drugs. Drugs/beta CD complexes obtained applying different techniques, eventually in solid state, usually show an improvement of solubility or at last in dissolution characteristics. In the present work, drug-bCD system or interacted products are prepared in order to screen different method of preparation in respect to the bioavailability increase (evaluated in vitro) and to the feasibility of the manufacturing process. From the galenical development point of view the beta CD/drug system prepared in different molar ratios were characterized by their physico-chemical properties (melting point, thermal behaviour by DSC, moisture content, IR spectrum, UV spectrum, equilibrium solubility, dissolution kinetics). The applied methods of preparation are well known industrial process as dry mixing (simple physical mixture), co-milling, kneading, coprecipitation, freeze drying, wet granulation methods. From the obtained in vitro results, it would seem that solubility and dissolution characteristics are improved by the drug-beta CD interaction, applying very common simply economic methods so the choice of the preferred manufacturing method will be delayed depending on in vivo performance and clinical needs and long term stability studies.
已知环糊精在水溶液中能与各种类型的有机物质形成包合物,也能与许多疏水性药物形成包合物。通过不同技术最终以固态形式获得的药物/β-环糊精复合物,通常显示出溶解度的提高或至少在溶出特性方面有所改善。在本工作中,制备药物-β-环糊精体系或相互作用产物,以便筛选不同的制备方法,考察其对生物利用度提高(体外评价)和生产工艺可行性的影响。从药剂学开发的角度来看,以不同摩尔比制备的β-环糊精/药物体系通过其物理化学性质(熔点、差示扫描量热法的热行为、水分含量、红外光谱、紫外光谱、平衡溶解度、溶出动力学)进行表征。所应用的制备方法是众所周知的工业工艺,如干混(简单物理混合物)、共研磨、捏合、共沉淀、冷冻干燥、湿法制粒等方法。从获得的体外结果来看,通过药物-β-环糊精相互作用,采用非常常见且经济的方法似乎可以改善溶解度和溶出特性,因此,首选生产方法的选择将取决于体内性能、临床需求和长期稳定性研究而推迟。